Follow Us:
Aspirin

Bayer

Aspirin

Aspirin is a non-steroidal anti-inflammatory drug (NSAID) used to relieve mild to moderate pain, reduce fever, and manage inflammation. At low doses, it inhibits platelet aggregation and is prescribed to help prevent blood clots in selected patients at risk of heart attack or ischaemic stroke. Aspirin works by irreversibly inhibiting cyclooxygenase enzymes, reducing the production of prostaglandins and thromboxane A₂. Common adverse effects include stomach irritation, nausea, and increased bleeding risk; serious complications can include gastrointestinal ulcers and bleeding. It should be used under medical guidance, particularly in people with bleeding disorders, stomach ulcers, aspirin-sensitive asthma, or those taking anticoagulants.

Dosage Form: Tablet
Dosage Strength:
CAS No.: 50-78-2
Status:
Manufacturer:
Group: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Sub Group: Non-selective COX inhibitors
Class: Salicylates

Uses of Aspirin

Aspirin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

  • Pain relief: Management of mild-to-moderate pain, including headache, dental pain, and musculoskeletal discomfort.
  • Fever reduction: Aspirin and selected salicylates may be used to reduce fever in appropriate adult patients.
  • Anti-inflammatory treatment: Management of selected inflammatory and musculoskeletal conditions.
  • Cardiovascular protection: Low-dose aspirin is used to reduce the risk of recurrent heart attack and ischaemic stroke in appropriately selected patients.
  • Rheumatic conditions: Certain salicylates have historically been used in the treatment of inflammatory joint disorders, although other medicines are now commonly preferred.
  • Dermatological applications: Salicylic acid is used topically for acne, psoriasis, warts, corns, and other conditions involving excessive skin scaling.

Contraindication of Aspirin

Aspirin was historically subject to specific precautions during administration to ensure patient safety. Its former precautions included:

  • Known hypersensitivity to aspirin or other salicylates.
  • Previous serious allergic reactions or aspirin-induced asthma.
  • Active peptic ulcer disease or gastrointestinal bleeding.
  • Significant bleeding disorders or active pathological bleeding.
  • Severe renal or hepatic impairment, depending on the medicine and formulation.
  • Children and adolescents with suspected or confirmed viral infections when aspirin is being considered.
  • Concurrent use of certain medicines or conditions that create an unacceptable bleeding risk.
  • Late pregnancy for analgesic or anti-inflammatory doses of aspirin, unless specifically directed by a specialist.

Precautions for Aspirin

Aspirin was majorly subjected to specific precautions during administration to ensure patient safety. Its former precautions included:

  • Gastrointestinal effects: Salicylates may cause stomach irritation, peptic ulcers, gastrointestinal bleeding, and abdominal discomfort.
  • Bleeding risk: Aspirin inhibits platelet aggregation and may increase the risk of bleeding, particularly in patients with bleeding disorders or those taking anticoagulants.
  • Kidney function: Use cautiously in patients with kidney impairment, dehydration, or conditions that may reduce renal blood flow.
  • Salicylate toxicity: Excessive doses may cause tinnitus, hearing disturbances, dizziness, sweating, nausea, vomiting, rapid breathing, and acid-base disturbances.
  • Asthma and allergies: Patients with aspirin-sensitive asthma or previous salicylate hypersensitivity should avoid these medicines unless specifically advised by a specialist.
  • Pregnancy: Aspirin and other salicylates require medical guidance during pregnancy. Low-dose aspirin may be prescribed for specific obstetric indications, whereas higher analgesic or anti-inflammatory doses carry additional risks.
  • Children and adolescents: Aspirin should generally be avoided in children and teenagers with viral infections because of the association with Reye's syndrome.
  • Surgical procedures: Patients taking aspirin should inform their healthcare professional before surgery or dental procedures because of its prolonged antiplatelet effect.

Drug Interactions for Aspirin

Potential drug interactions were historically documented when Aspirin was prescribed alongside certain medications. These included:

  • Anticoagulants: Warfarin and direct oral anticoagulants may increase the risk of bleeding when combined with aspirin.
  • Antiplatelet medicines: Clopidogrel and other antiplatelet agents may increase bleeding risk when used with aspirin.
  • NSAIDs: Ibuprofen and other NSAIDs may increase gastrointestinal adverse effects. Ibuprofen can also interfere with aspirin's antiplatelet effect depending on the timing and formulation.
  • Corticosteroids: Concurrent use may increase the risk of gastrointestinal ulcers and bleeding.
  • Methotrexate: Salicylates may reduce methotrexate elimination and increase the risk of toxicity, particularly at higher doses.
  • Antidiabetic medicines: Aspirin, particularly at higher doses, may enhance the glucose-lowering effects of certain medicines.
  • Valproic acid: Aspirin may increase free valproate concentrations and the risk of adverse effects.
  • Alcohol: Alcohol consumption may increase the risk of gastrointestinal irritation and bleeding.
  • Uricosuric medicines: Salicylates may interfere with the uric-acid-lowering effects of medicines such as probenecid, depending on the dose.

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Aspirin.

The Acetylsalicylic Acid is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Aspirin.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Aspirin, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Aspirin Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Aspirin

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Aspirin Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Aspirin, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Aspirin

The export of Aspirin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Aspirin Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Aspirin specifications, certificates of analysis, and other supporting documents required for Aspirin export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Aspirin export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Aspirin regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Aspirin documentation, labelling, Aspirin manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Aspirin Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Aspirin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.